COGNITION THERAPEUTICS INC
Nasdaq: CGTXBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0001455365
TickerCGTX
ExchangeNasdaq
SIC2836
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$23.49M
+30.9% YoY
Total AssetsFY2025-12-31
$48.39M
+60.1% YoY
EquityFY2025-12-31
$34.27M
+82.8% YoY
Shares OutstandingFY2025-12-31
89.35M
—
Operating Cash FlowFY2025-12-31
-$24.59M
+13.6% YoY
Market
Market
CGTXClose price
$1.45
Market cap
$129.77M
delayed EOD · as of 2026-06-18
Short interest & fails
Short-sale volume
FINRA Reg SHO · daily34.4%
short of total volume · 2026-06-18
2026-06-1834.4%
2026-06-1749.3%
2026-06-1641.8%
2026-06-1557.8%
2026-06-1264.8%
Fails-to-deliver
SEC CNS fails · semi-monthly28.59K
shares failed · 2026-05-29
2026-05-2928.59K sh$1.19
2026-05-28722 sh$1.19
2026-05-275.21K sh$1.24
2026-05-2185 sh$1.29
2026-05-048.8K sh$1.28
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$21.4M | -$25.79M | -$33.97M | -$23.49M | +30.9% | — |
| Total Assets | $50.43M | $35.16M | $30.23M | $48.39M | +60.1% | — |
| Equity | $40.25M | $24.47M | $18.75M | $34.27M | +82.8% | — |
| Operating Cash Flow | -$18.53M | -$16.02M | -$28.47M | -$24.59M | +13.6% | — |
| Shares Outstanding | — | — | — | 89.35M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001455365